K-12 edtech unicorn Vedantu is navigating a pivotal phase in its journey. As India’s edtech landscape recalibrates in the post-pandemic world, Vedantu is reportedly inView More
Gabriel India’s Quiet Reinvention: Can a Suspension Giant Ride the Premiumisation Wave?
As the auto component industry grapples with rapid innovation, cost pressures, and an electrifying future, one of its legacy players is plotting a bold, albeitView More
Riding Against the Current: How India’s Outliers Are Powering Profit Growth in a Turbulent FY25
In a year where corporate India has been battered by economic headwinds, five companies—Bharti Airtel, Adani Enterprises, Tech Mahindra, Apollo Hospitals, and Hindalco—have bucked theView More
⚛️ Powering Progress: India’s Bold Leap into Small Modular Nuclear Reactors
India’s energy landscape is witnessing a strategic and transformative shift with the launch of the Bharat Small Reactors (BSRs) program—an ambitious initiative to set upView More
India’s Hospitality Sector at a Watershed Moment: Inside the ₹10,000 Cr Investment Wave
India’s hospitality industry is undergoing a paradigm shift. A confluence of IPOs, strategic acquisitions, and bold capital infusion — crossing the ₹10,000 crore mark sinceView More
Tragedy and Turbulence: The Modern Struggles of India’s Oldest Airline
A Fateful Thursday: Catastrophe in the Skies India awoke to shock and sorrow on Thursday as one of its most iconic airlines—Air India—suffered a devastatingView More
Adani Ports Charts a Bold Course to FY29: Can It Deliver?
India’s largest port operator, Adani Ports and Special Economic Zone Ltd (APSEZ), is setting sail toward a remarkably ambitious destination. After a robust FY25, theView More
ICICI Lombard’s Ascent: A Motor for Growth in the General Insurance Landscape
The general insurance sector has found itself in the investor spotlight, spurred by reports suggesting the Ministry of Road Transport and Highways is contemplating anView More
Laurus Labs: From Pandemic Windfall to CDMO-Led Revival
The Meteoric Rise In the aftermath of the global health crisis, a relatively obscure pharma player stunned markets. Laurus Labs’ stock multiplied tenfold between MarchView More